GLP-1 shots, including popular brands such as Ozempic and Wegovy for semaglutide and Mounjaro for tirzepatide, mimic the ...
The updated guidance for people aged 16 and over recommends using smaller amounts of intravenous fluid initially for those at risk of serious illness or death due to sepsis. Patients should be ...
Background Renal denervation (RDN) has emerged as a guideline-recommended therapeutic option in hypertension management with ...
The British Association of Sexual Health and HIV has published new treatment guidelines in an attempt to prevent the sexually transmitted infection mycoplasma genitalium, also known as MGem or MG, ...
A major UK reaudit shows significant improvements in outcomes for patients with acute upper GI bleeding and highlights clear ...
Patients over 16 years with suspected sepsis should get smaller amounts of intravenous fluid initially and then have regular reassessments to tailor treatment, updated guidelines recommend.1 At least ...
‘World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults’ by Francesca Celletti et al. was published in JAMA at 13:45 ...
New guidance published in Anaesthesia (the journal of the Association of Anaesthetists) provides clear advice to reduce avoidable errors on all steps of the pathway involving injectable medications ...
The World Health Organization (WHO) on Monday issued its first-ever global guidelines on the use of GLP-1 medications for treating obesity as a chronic illness. In a press release, the WHO said this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback